Crossmark

Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD+-dependent sirtuin-3 activation

Crossref DOI link: https://doi.org/10.1038/s12276-025-01445-w

Published Online: 2025-05-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Qinqiu

Guo, Yanjun

Chen, Shenghui

Liu, Zhening

Wang, Xinyu

Huang, Hangkai

Shen, Qi-en

Yang, Ling

Li, Meng

Li, Youming

Yu, Chaohui https://orcid.org/0000-0003-4842-3646
Xu, Chengfu https://orcid.org/0000-0002-6172-1253
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82070585, 81770573, 81722009, 82370574)
License Information

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-05-01
More Information

Article History

Received: 7 July 2024

Revised: 8 February 2025

Accepted: 18 February 2025

First Online: 1 May 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below